Compare MLCI & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLCI | ARAY |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | United States |
| Employees | 21 | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.4M | 39.3M |
| IPO Year | N/A | 2006 |
| Metric | MLCI | ARAY |
|---|---|---|
| Price | $3.07 | $0.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 12.6K | ★ 1.3M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.58 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.68 | $0.22 |
| 52 Week High | $8.68 | $2.10 |
| Indicator | MLCI | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 40.49 | 49.81 |
| Support Level | $2.70 | $0.24 |
| Resistance Level | $3.13 | $0.29 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 6.56 | 59.13 |
Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The company's reporting segments include asset management and insurance. The company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The Asset Management segment comprises all fee generating activities. The Insurance Solutions segment, which derives maximum revenue, consists of two product lines within the insurance business, LTC and MYGA.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.